BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,146,000 | +0.5% | 63,979 | +0.6% | 1.52% | 0.0% |
| Q2 2021 | $5,120,000 | +2.4% | 63,597 | +7.3% | 1.52% | -6.9% |
| Q1 2021 | $4,999,000 | +6.6% | 59,281 | -0.4% | 1.63% | -40.1% |
| Q4 2020 | $4,689,000 | +3.4% | 59,491 | +5.5% | 2.72% | -15.5% |
| Q3 2020 | $4,534,000 | +14.4% | 56,386 | +22.5% | 3.22% | +7.8% |
| Q2 2020 | $3,964,000 | -9.2% | 46,043 | -14.4% | 2.98% | +2.6% |
| Q1 2020 | $4,365,000 | -2.5% | 53,765 | +0.4% | 2.91% | +4.6% |
| Q4 2019 | $4,479,000 | -4.0% | 53,572 | +0.4% | 2.78% | -10.9% |
| Q3 2019 | $4,666,000 | +31.8% | 53,347 | +23.4% | 3.12% | +26.7% |
| Q2 2019 | $3,539,000 | +8.3% | 43,223 | +7.5% | 2.46% | +0.7% |
| Q1 2019 | $3,267,000 | +8.0% | 40,189 | -12.6% | 2.45% | -11.1% |
| Q4 2018 | $3,025,000 | – | 45,960 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |